Iñigo Rubio-Baines

Dr. Iñigo Rubio-Baines

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
LCLuigi Camporota
Luigi Camporota
DGDuilio González-Delgado
Duilio González-Delgado
GEGemma Echarri
Gemma Echarri
MSMaria Carmen Sala-Trull
Maria Carmen Sala-Trull
Marc VivesMarc Vives
Marc Vives
Background: Human serum albumin (HSA), the most abundant plasma protein, is essential for oncotic pressure, endothelial protection, drug binding, and immune modulation. Despite its widespread clinical use since the 1940s, its therapeutic benefit in critically ill patients remains debated. This narrative review summarizes current evidence on HSA use in common intensive care scenarios. Clinical Applications: In hepatorenal syndrome (HRS), albumin combined with vasoconstrictors like terlipressin improves renal function and survival. In spontaneous bacterial peritonitis (SBP), albumin lowers the risk of acute kidney injury and mortality, particularly in high-risk cirrhotic patients. Post-paracentesis albumin reduces circulatory dysfunction and may enhance survival in cirrhosis. For septic shock, trials show no overall mortality benefit over crystalloids, though albumin may offer hemodynamic advantages in specific subgroups. In acute respiratory distress syndrome (ARDS), albumin improves oxygenation in hypoalbuminemic patients, without survival benefits. During major cardiac or abdominal surgery, albumin reduces fluid needs and postoperative complications, especially in hypoalbuminemic individuals. In acute brain injury, albumin’s role is controversial: it may aid recovery after cerebral hemorrhage, but can worsen outcomes in traumatic brain injury. In trauma and ECMO patients, albumin may stabilize hemodynamics and improve outcomes in selected cases. Conclusions: Inappropriate albumin use remains common, and evidence on its optimal concentration, dose, timing, and patient selection is limited. HSA is safe and beneficial in specific situations. Routine use should follow evidence-based guidelines. Future research must identify patients who are most likely to benefit and clarify optimal dosing strategies, concentrations, and therapeutic goals.

6 July 2023 in British Journal of Anaesthesia
Verified
Journal Article
Open access
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
CHCristina Maria Honorato-Cia
Cristina Maria Honorato-Cia
Miguel ValenciaMiguel Valencia
Miguel Valencia
APAlfredo Panadero
Alfredo Panadero
ECElena Cacho-Asenjo
Elena Cacho-Asenjo
MAMartinez-Simon Antonio
Martinez-Simon Antonio
Sugammadex has been associated with increases in the bispectral index (BIS). We evaluated the effects of sugammadex administration on quantitative electroencephalographic (EEG) and electromyographic (EMG) measures. We performed a prospective observational study of adult male patients undergoing robot-assisted radical prostatectomy. All patients received a sevoflurane-based general anaesthetic and a continuous infusion of rocuronium, which was reversed with 2 mg kg-1 of sugammadex i.v. BIS, EEG, and EMG measures were captured with the BIS Vista™ monitor. Twenty-five patients were included in this study. Compared with baseline, BIS increased at 4-6 min (β coefficient: 3.63; 95% confidence interval [CI]: 2.22-5.04; P<0.001), spectral edge frequency 95 (SEF95) increased at 2-4 min (β coefficient: 0.29; 95% CI: 0.05-0.52; P=0.016) and 4-6 min (β coefficient: 0.71; 95% CI: 0.47-0.94; P<0.001), and EMG increased at 4-6 min (β coefficient: 1.91; 95% CI: 1.00-2.81; P<0.001) after sugammadex administration. Compared with baseline, increased beta power was observed at 2-4 min (β coefficient: 93; 95% CI: 1-185; P=0.046) and 4-6 min (β coefficient: 208; 95% CI: 116-300; P<0.001), and decreased delta power was observed at 4-6 min (β coefficient: -526.72; 95% CI: -778 to -276; P<0.001) after sugammadex administration. Neither SEF95 nor frequency band data analysis adjusted for EMG showed substantial differences. None of the patients showed clinical signs of awakening. After neuromuscular block reversal with 2 mg kg-1 sugammadex, BIS, SEF95, EMG, and beta power showed small but statistically significant increases over time, while delta power decreased.

29 June 2022 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Open access
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
ASA. Panadero Sánchez
A. Panadero Sánchez
EDE. Belinchón de Diego
E. Belinchón de Diego
JCJ. Colombas
J. Colombas
AAA. Martínez Alcaraz
A. Martínez Alcaraz
La inducción anestésica inhalatoria con sevoflurano es muy empleada en la población pediátrica. Si bien los efectos sistémicos más comunes son ampliamente conocidos, no se conocen todos los efectos secundarios de este fármaco. Presentamos el caso clínico de un varón de cuatro años que desarrolló un episodio de taquicardia supraventricular sostenida tras la inducción anestésica con sevoflurano, que no cedió hasta que no se retiró el fármaco y se sustituyó el mantenimiento anestésico por una perfusión continua de fármacos hipnóticos intravenosos (propofol y remifentanilo). Desconocemos el mecanismo exacto por el que este episodio ha tenido una relación causal tan clara con la administración de sevoflurano; las posibilidades diagnósticas serían la taquicardia por reentrada intranodal o la existencia de una vía accesoria. No hemos encontrado en la literatura un episodio de taquicardia supraventricular mantenida con una relación causal directa con la administración de sevoflurano como en el caso que presentamos.

31 August 2023 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Open access
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
MAMartinez-Simon Antonio
Martinez-Simon Antonio
FAFrancisco Javier Ancizu
Francisco Javier Ancizu
IOIsidro Olavide
Isidro Olavide
CHCristina Maria Honorato-Cia
Cristina Maria Honorato-Cia
Robot-assisted radical prostatectomy is a relatively recent technique. Its advantages include less invasiveness and better pain management, but has specific anesthesia requirements, such as steep Trendelenburg position and pneumoperitoneum. Mild complications are common, e.g., transient hypotension or soft tissue edema. We present a case of a 62-year old male who developed subgaleal hematoma associated with transient neurologic impairment after surgery. Jugular vein insufficiency was suspected as the most likely cause. The patient recovered fully. Robot-assisted radical prostatectomy can be a challenging procedure due to the anesthesia requirements, but most complications are mild and transient. However, patients should be carefully assessed before surgery. We identified potential factors that may have led to this complication: the abnormal prolonged surgical time, the steep Trendelenburg, a non-assessed jugular vein insufficiency, and/or patient`s obesity.

1 July 2026 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
ACAngel Candela
Angel Candela
GEGemma Echarri
Gemma Echarri
RCRaquel Callejas
Raquel Callejas
ETEduardo Tamayo
Eduardo Tamayo
Marc VivesMarc Vives
Marc Vives
The impact of preoperative Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (ACEI/ARB) on cardiac surgery-associated Acute Kidney Injury (AKI) remains elusive. We sought to evaluate the association of ACEI/ARB use with stage 2 or 3 AKI and in-hospital mortality, while evaluating whether preoperative withholding versus continuation strategies modulate clinical outcomes. Multicenter prospective cohort study involving 14 Spanish and British hospitals. The study population comprised high-risk cardiac surgery patients (Cleveland Clinic Score ≥ 4). Among 249 patients (mean age: 69.5-years; 39% women; 53.8% ACEI/ARB users), the overall incidence of stage 2 or 3 AKI was 32.9%. ACEI/ARB use was associated with a significantly higher likelihood of stage 2 to 3 AKI (38.8% vs. 26.1%; adjusted OR = 2.79; 95% CI 1.47-5.30; p = 0.002). The adjusted risk difference was 0.188 (95% CI 0.079-0.298; p = 0.001), yielding a number needed to harm of 5.3. Sensitivity analyses confirmed the robustness of these findings, with an E-value of 2.73 (lower limit: 1.72) and consistent results using augmented inverse probability weighting (average treatment effect: 0.191; 95% CI 0.081-0.300; p = 0.001). No statistically significant associations were observed in in-hospital mortality or the impact of preoperative withholding versus continuation strategies on clinical outcomes. This study suggests preoperative ACEI/ARB use may be associated with an increased incidence of stage 2 or 3 AKI. While differences in in-hospital mortality and preoperative withholding versus continuation strategies did not reach statistical significance, these findings reveal clinical trends that warrant further investigation.

22 December 2025 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
AMAntonio Martinez-Simon
Antonio Martinez-Simon
MVMiguel Valencia
Miguel Valencia
APAlfredo Panadero
Alfredo Panadero
ECElena Cacho-Asenjo
Elena Cacho-Asenjo
CHCristina Honorato-Cia
Cristina Honorato-Cia
Measurements from level of anesthesia monitors can be influenced by various factors. This study aimed to compare the evolution of BIS Vista™ monitor and electroencephalogram (EEG) parameters over time during steep Trendelenburg positioning. In this prospective observational study, data were collected from patients undergoing robot-assisted radical prostatectomy. BIS Vista™ monitor parameters (BIS Index, SEF95, EEG-BIS) and a 4-electrode EEG setup (EEG-BrVis) were recorded at baseline, 30 min after Trendelenburg positioning, and every 60 min until procedure completion. Parameter changes from baseline and trends over time were analyzed. Eighteen patients were analyzed. The mean surgical duration was 269 ± 69 min, with Trendelenburg angles ranging from 32º to 41º. No significant changes were observed in BIS Index or SEF95 in trend over the time. Mean changes in BIS Index were 0.017 ± 0.01 ( p = 0.096) and 0.016 ± 0.011 ( p = 0.162); SEF95 changes were − 0.002 ± 0.002 Hz ( p = 0.390) and − 0.002 ± 0.002 Hz ( p = 0.326) for left and right hemispheres, respectively. However, the area under the curve of the power spectral ( p < 0.001) and all frequency bands power ( p < 0.001) showed a significant decrease over the time in both EEG. Minimal changes without clear pattern were observed in spectral slope during the study. BIS Index and SEF95 remained consistent during prolonged Trendelenburg positioning. The reduction in EEG singal power across 0–45 Hz caused a vertical shift in the power spectrum with minimal changes in its spectral profile. Facial tissue edema by positioning plays a primary role in the EEG signal power reduction.